Benefit of mycophenolate mofetil in patients with cyclosporine A- induced nephropathy after lung transplantation

Transplantation Proceedings

Volumn 31, Issue 1-2, 1999, Pages 1160-1161

  Zuckermann, A ^a   Birsan, T ^a   Thaghavi, S ^a   Kupilik, N ^a   Deviatko, E ^b   Dekan, G ^b   Wolner, E ^a   Klepetko, W ^a  

^a TB ST NK EW WK) U ^*  (Austria)

^b UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN A; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; TACROLIMUS; THYMOGLOBULIN IMTIX; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DOSE RESPONSE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; FOLLOW UP; GASTROINTESTINAL TOXICITY; GRAFT REJECTION; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY DISEASE; KIDNEY FUNCTION; LEUKOPENIA; LUNG TRANSPLANTATION; MALE; MORTALITY; MUSCLE HYPERTONIA; PRIORITY JOURNAL; RASH; TREATMENT INDICATION;

ADOLESCENT; ADULT; AZATHIOPRINE; CREATININE; CYCLOSPORINE; DRUG THERAPY, COMBINATION; FEMALE; GRAFT REJECTION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY; KIDNEY FUNCTION TESTS; LUNG TRANSPLANTATION; MALE; METHYLPREDNISOLONE; MIDDLE AGED; MYCOPHENOLIC ACID; SURVIVAL RATE; TACROLIMUS;

EID: 0033025325     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0041-1345(98)01945-9     Document Type: Conference Paper

References (7)

1. Eugui E.M., Almquist S.J., Muller C.D., et al. Scand J Immunol. 33:1991;161.
2. Transplantation. 60:1995;225.
3. Transplantation. 61:1996;1029.
4. Lancet. 345:1995;1321.
5. Yousem S.A., Berry G.J., Cagle P.T., et al. J Heart Lung Transplant. 15:1996;1.
6. Paradis I.L., Yousem S.A., Griffith B.P. King T.E. Bronchiolitis Clinics in Chest Medicine . 1993;751 Saunders, Philadelphia.
7. Bando K., Paradis I.L., Komatsu K., et al. J Thorac Cardiovasc Surg. 109:1995;49.